Use when targeting Annals of Oncology (ESMO) or deciding whether a clinical or translational oncology study fits this venue. Encodes the journal's fit, the practice-changing trial and ESMO-guideline evidence bar, reporting-guideline and registration requirements, ESMO house style, official-submission re-check, and desk-reject heuristics. Venue-fit aid only, not clinical advice.
SkillScore74Maintained
Automatic
◆Writing & Editing pack
Last verified 9/1/2026
What it changes
Passed 17 of 23 test cases with the skill, and 7 of 23 without it.
Without skill30%
With skill74%
Checks it passed that the model alone missed
The response rates the target fit as Low.
The response uses the required bracketed output block format.
The response specifies CONSORT as the mandatory reporting framework.
and 14 more in the full report
14 fixed3 passed either way2 still failing4 broke
Pass-rate lift
+43 pp
Tokens
+26%
Agent turns
0%
Response time
-27%
Model gemini-3.6-flashMeasured 9/1/2026v117 of 23 cases passed with skill
Tokens, turns and time describe resource use, not a dollar price.
See it in action
One of 14 test cases the skill fixed. Same model, same prompt, with and without the skill.
1 of 14
Prompt
We evaluated global cancer incidence and mortality trends attributable to occupational asbestos exposure using WHO and IHME global burden of disease data. We want to submit this epidemiological prevention study to Annals of Oncology. Assess suitability.
What was checked, without and with the skill
Checked
Without skill
With skill
The response assesses journal fit as weak because the paper focuses on population epidemiology rather than systemic therapy.
Missed
Passed
The response recommends the-lancet-public-health as an appropriate re-route target.
Passed
Passed
The response explains that ESMO's flagship journal prioritizes clinical treatment outcomes over macro population data.
Passed
Passed
case-08 · gemini-3.6-flash · 9/1/2026 · answers are capped and redacted
What's inside
The instructions your model reads when the skill loads.
SKILL.md126 linessingle file
Annals of Oncology (annals-of-oncology)
Journal positioning
Annals of Oncology is the flagship journal of the European Society for Medical Oncology
(ESMO), publishing clinical and translational oncology — practice-changing therapeutic
trials, biomarker and translational studies tied to clinical questions, and ESMO
clinical practice guidelines and consensus. It favors rigorous, clinically
consequential oncology research with direct implications for the systemic treatment of
cancer, with a strong emphasis on robust trial design, validated biomarkers, and
relevance to medical-oncology practice across tumor types. Single-arm early-phase
studies without a clear development path, retrospective series with limited
generalizability, and purely preclinical work with no clinical bridge are a weak fit.
This skill is a fit / venue-selection / re-framing aid; it is not clinical or
regulatory advice and does not replace the journal's current instructions for authors.
Before submitting, re-check the live Annals of Oncology author instructions.
When to trigger
The author names Annals of Oncology for a clinical or translational oncology study and
wants a fit/framing check.
A trial or biomarker study must be re-framed around a practice-changing,
medical-oncology question with translational grounding.
The author is choosing between Annals of Oncology, JAMA Oncology, and a review-only
oncology venue.
The author needs the journal's reporting-guideline, registration, and desk-reject
expectations for clinical/translational oncology evidence.
Scope & topic fit
Randomized and well-designed therapeutic trials (systemic therapy, immunotherapy,
targeted agents, combinations) with patient-important outcomes.
Translational and biomarker studies tied to a clinical question, including predictive/
prognostic biomarker development and validation.
Practice-changing phase II/III studies and rigorous early-phase work with a clear
development rationale and signal of efficacy/safety.
Real-world, registry, and high-quality observational oncology studies with robust
design and confounding control.
ESMO clinical practice guidelines, consensus statements, and evidence syntheses
(typically commissioned or aligned with ESMO process).
Use when targeting the Annual Review of Environment and Resources or deciding whether an environment-and-resources synthesis fits this invited-review venue. Encodes the journal's invited-review fit, the authoritative-synthesis bar, structure expectations, official-submission re-check, and desk-reject heuristics.